Vistin Pharma ASA (OSL:VISTN)
Norway · Delayed Price · Currency is NOK 23.30
-0.30 (-1.27%)
At close: Sep 16, 2025
Vistin Pharma ASA Market Cap
Vistin Pharma ASA has a market cap or net worth of 1.03 billion as of September 17, 2025. Its market cap has increased by 0.43% in one year.
Market Cap
1.03B
Enterprise Value
1.12B
Revenue
452.25M
Ranking
n/a
PE Ratio
13.58
Stock Price
23.30
Market Cap Chart
Since June 10, 2015, Vistin Pharma ASA's market cap has increased from 322.34M to 1.03B, an increase of 220.54%. That is a compound annual growth rate of 12.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 1.03B | -1.69% |
| Dec 30, 2024 | 1.05B | 1.72% |
| Dec 29, 2023 | 1.03B | 47.47% |
| Dec 30, 2022 | 700.64M | -18.47% |
| Dec 30, 2021 | 859.40M | 11.06% |
| Dec 30, 2020 | 773.81M | 67.79% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 4.48B |
| Nordhealth AS | 2.78B |
| Thor Medical ASA | 1.66B |
| Photocure ASA | 1.58B |
| ArcticZymes Technologies ASA | 1.31B |
| Omda AS | 998.72M |
| Gentian Diagnostics ASA | 848.23M |
| Lytix Biopharma AS | 495.58M |